Luck. Bisantrene was always of some interest with its lack of cardiotoxicity as a chemo agent, but in the middle of last year it was discovered by a team out of the City of Hope in Los Angels that Bisantrene is also a very potent inhibitor of the FTO protein. FTO has recently been discovered to be important is a huge number of cancers (basically all) and also to overcome treatment resistance to a huge range of cancer treatments. Bisantrene has gone from being a bit of niche drug targeting AML, to be centre stage in the hottest area of oncology today.
Medical / Clinical Discussions, page-468
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |